Manjula Patel, MD (New York, NY),* Jordi Mones, MD (Barcelona, Spain), Anita Leys, PhD, MD (Leuven, Belgium), Gergana Zlateva, PhD (New York, NY),* Sonali N. Shah, BS Pharm, MPH (New York, NY)* PURPOSE: Patients with AMD are more likely to need help with daily activities, experience more emotional distress, and report a reduced quality of life than those without AMD. Pegaptanib sodium is the first pharmacological treatment for subfoveal...

Read More